KalVista Pharmaceuticals, Inc. (KALV)

SEC filing

KalVista Pharmaceuticals, Inc.

KALV · CIK 1348911

4 · Feb 24, 2026 · Piekos Brian sold 1,767 shares at $15.57/share ($27,507); exercised options for 5,000 shares

Piekos Brian sold 1,767 shares at $15.57/share ($27,507); exercised options for 5,000 shares

xslF345X05/form4-02252026_120203.xml

xslF345X05/form4-02252026_120203.xmlSEC.gov

Graphics and non-inline formats (not embedded below).